Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)

NCT02047227 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

939

Enrollment

INDUSTRY

Sponsor class

Conditions

Infertility

Interventions

DRUG: Pergoveris®
DRUG: GONAL-f®
DRUG: Recombinant human chorionic gonadotrophin (r-hCG)

Sponsor

Merck KGaA, Darmstadt, Germany